UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...
Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...
Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.
Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how it can be treated is important for staying healthy. The prostate is a small ...
Add Yahoo as a preferred source to see more of our stories on Google. Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped ...
No one ever expects a chronic change in their health. So when my urologist said in 2019 that my PSA test showed the most aggressive form of prostate cancer, I was not prepared. I was 68, and my annual ...
COLORADO SPRINGS, Colo. (KRDO) -- September is prostate cancer awareness month, a time to focus on one of the most common cancers affecting men. The American Cancer Society estimates more than 300,00 ...